Today the Menarini Group is the largest Italian pharmaceutical group in the world.

In the 1960’s Menarini understood the importance of broadening its horizons beyond Italy. In fact, the establishment of Laboratorios Menarini of Barcelona, Spain dates back to this period.

In the 1970’s Menarini's position in Italy was strengthened following a decade of co-marketing agreements made with other Italian pharmaceutical companies.

Once Menarini achieved leadership in the Italian market in the 1990's, it focused on expanding throughout Europe and the world by acquiring or opening affiliate companies.

Today the Menarini Group is present:

• in all countries of the European Union

• in Switzerland

• in the Central and Eastern European region where it is among the major international pharmaceutical groups, particularly in Russia, in the Baltic countries, and the other countries of the ex-Soviet Union

• In Turkey with the acquisition of I.E. Ulagay in 2000

• In Central America where it ranks fifth

• In the principal emerging countries such as India (from 1995), Vietnam (from 1994), the People's Republic of China and Korea

• In South Africa

• In Argentina (since 2001)

• In Mexico (2008)

The Group is also present with its own products in over 100 countries of the world through agents and local distributors.

The Menarini Group is the leading Italian pharmaceutical group in the world.

It ranks at the following positions:

• 15 ^th in Europe out of 4,881 companies

• 34 ^th in the world out of 14,051 companies

(IMS World Review 2010, IMS World Review Pack 2010 per number of companies)